Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy HSBC Holdings (HSBA) by Simon Watkins in The Motley Fool
- Buy SSE (SSE) by Berenberg
- Buy Town Centre Securities (TOWN) by Russ Mould in The Telegraph - Questor
- Hold GSK (GSK) by Russ Mould in The Telegraph - Questor
- Buy Unilever (ULVR) by Mark Rogers in The Motley Fool
- Buy Greencoat UK Wind (UKW) by Royston Wild in The Motley Fool
- Buy BlackRock Greater Europe Inv Trust (BRGE) by Lauren Almeida in The Times - Tempus
- Hold Tristel (TSTL) by Kevin Godbold in The Motley Fool
- Buy Golden Prospect Precious Metals Ltd. (GPM) by Nigel Somerville in ShareProphets
- Avoid SIG (SHI) by Steve Moore in ShareProphets
- Avoid Fonix (FNX) by Steve Moore in ShareProphets
- Watch British Land Company (BLND) by Jon Smith in The Motley Fool
- Sell React Group (REAT) by Hot Stock Rockets in ShareProphets
- Buy AstraZeneca (AZN) by Simon Watkins in The Motley Fool
- Buy Experian (EXPN) by UBS
- Neutral Rentokil Initial (RTO) by UBS
- Neutral Ashtead Group (AHT) by UBS
- Buy DCC (CDI) (DCC) by UBS
- Neutral RS Group (RS1) by UBS
- Buy Yellow Cake (YCA) by Citi
GSK (GSK) Share Price
Health Care Sector
NOTE: This is based on 1,349 open tips for GSK (GSK)
| Latest Bid : 1,456.00p | Latest Ask : 1,457.00p |
| High Today : 1,464.00p | Low Today : 1,455.61p |
| This Years High : 1,812.50p | This Years Low : 1,382.00p |
| Volume : 180,891 | MKT Cap : £60392.65M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
GSK (GSK) Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.GSK (GSK) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Russ Mould | Premium Only | 2024-10-22 05:00:00 22/10/2024 | -0.17% |
| Neutral | Goldman Sachs | Premium Only | 2024-10-03 06:20:00 03/10/2024 | – |
| Buy | Jefferies | Premium Only | 2024-10-03 04:55:00 03/10/2024 | -2.08% |
| Equal Weight | Barclays | Premium Only | 2024-10-01 05:50:00 01/10/2024 | 2.85% |
| Buy | Simon Watkins | Premium Only | 2024-09-09 07:35:00 09/09/2024 | -12.55% |
GSK (GSK) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 1,456.00p | Latest Ask : 1,457.00p |
| High Today : 1,464.00p | Low Today : 1,455.61p |
| This Years High : 1,812.50p | This Years Low : 1,382.00p |
| Volume : 180,891 | MKT Cap : £60392.65M |
GSK Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest GSK Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Russ Mould | Premium Only | 2024-10-22 05:00:00 22/10/2024 | -0.17% |
| Neutral | Goldman Sachs | Premium Only | 2024-10-03 06:20:00 03/10/2024 | – |
| Buy | Jefferies | Premium Only | 2024-10-03 04:55:00 03/10/2024 | -2.08% |
| Equal Weight | Barclays | Premium Only | 2024-10-01 05:50:00 01/10/2024 | 2.85% |
| Buy | Simon Watkins | Premium Only | 2024-09-09 07:35:00 09/09/2024 | -12.55% |